vs
Side-by-side financial comparison of GAXOS.AI INC. (GXAI) and Picard Medical, Inc. (PMI). Click either name above to swap in a different company.
GAXOS.AI INC. is the larger business by last-quarter revenue ($1.2M vs $1.2M, roughly 1.0× Picard Medical, Inc.). GAXOS.AI INC. runs the higher net margin — -77.2% vs -878.3%, a 801.1% gap on every dollar of revenue.
GXAI vs PMI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Net Profit | $-957.9K | $-10.4M |
| Gross Margin | — | -11.0% |
| Operating Margin | -99.0% | -293.8% |
| Net Margin | -77.2% | -878.3% |
| Revenue YoY | 94996.3% | — |
| Net Profit YoY | -15.1% | — |
| EPS (diluted) | $-0.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | — | ||
| Q3 25 | $498.3K | $1.2M | ||
| Q2 25 | $171.0K | $2.1M | ||
| Q2 24 | $0 | — |
| Q4 25 | $-957.9K | — | ||
| Q3 25 | $-1.0M | $-10.4M | ||
| Q2 25 | $-749.4K | $-6.7M | ||
| Q2 24 | $-809.2K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | — | -6.0% | ||
| Q2 24 | — | — |
| Q4 25 | -99.0% | — | ||
| Q3 25 | -263.9% | -293.8% | ||
| Q2 25 | -574.8% | -165.2% | ||
| Q2 24 | — | — |
| Q4 25 | -77.2% | — | ||
| Q3 25 | -201.0% | -878.3% | ||
| Q2 25 | -438.3% | -315.5% | ||
| Q2 24 | — | — |
| Q4 25 | $-0.13 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q2 24 | $-0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $840.5K | $2.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.1M | $8.0M |
| Total Assets | $13.4M | $13.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $840.5K | — | ||
| Q3 25 | — | $2.8M | ||
| Q2 25 | — | $410.0K | ||
| Q2 24 | $4.5M | — |
| Q4 25 | $13.1M | — | ||
| Q3 25 | $14.1M | $8.0M | ||
| Q2 25 | $15.0M | $-54.5M | ||
| Q2 24 | $4.7M | — |
| Q4 25 | $13.4M | — | ||
| Q3 25 | $14.3M | $13.5M | ||
| Q2 25 | $15.4M | $11.7M | ||
| Q2 24 | $5.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-733.1K | $-6.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-733.1K | — | ||
| Q3 25 | $-1.1M | $-6.5M | ||
| Q2 25 | $-716.9K | $-4.8M | ||
| Q2 24 | $-738.5K | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GXAI
Segment breakdown not available.
PMI
| Products | $1.1M | 94% |
| Other | $72.0K | 6% |
